Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks

Medtronic is facing a mix of opportunities and challenges in its market landscape. Strong performance in areas like neuromodulation and strategic partnerships signal growth potential, but operational inefficiencies and competitive pressures pose risks.